Sigma antagonists potentiate opioid analgesia in rats Journal Article


Authors: Chien, C. C.; Pasternak, G. W.
Article Title: Sigma antagonists potentiate opioid analgesia in rats
Abstract: In mice, activation of sigma, receptors antagonizes opioid analgesia. Sigma antagonists potentiate opioid analgesia, implying that the anti-opioid sigma system is tonically active. Co-administration of haloperidol with the mu opioid morphine, the kappa1 analgesic U50,488H or the kappa3 agonist naloxone benzoylhydrazone enhances the analgesic activity of all agents. The effect results from sigma receptor blockade since (-)sulpiride, a selective D2 antagonist which does not block sigma receptors, is inactive. © 1995.
Keywords: controlled study; unclassified drug; nonhuman; animal; haloperidol; animal experiment; drug synergism; rat; rats; rats, sprague-dawley; morphine; pain measurement; analgesics; analgesia; mu opiate receptor; naloxone; pyrrolidines; opiate antagonist; receptors, sigma; 3,4 dichloro n methyl n [2 (1 pyrrolidinyl)cyclohexyl]benzeneacetamide methanesulfonate; kappa opiate receptor; opioid analgesia; subcutaneous drug administration; narcotics; priority journal; article; support, non-u.s. gov't; support, u.s. gov't, p.h.s.; 3,4-dichloro-n-methyl-n-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-isomer; sulpiride; sigma, receptors; naloxone derivative
Journal Title: Neuroscience Letters
Volume: 190
Issue: 2
ISSN: 0304-3940
Publisher: Elsevier Science, Inc.  
Date Published: 1995-05-05
Start Page: 137
End Page: 139
Language: English
DOI: 10.1016/0304-3940(95)11504-p
PUBMED: 7644123
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 28 August 2018 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gavril W Pasternak
    414 Pasternak
Related MSK Work